Dose-threshold for thyroid tumor-promoting effects of orally administered kojic acid in rats after initiation with N-bis(2-hydroxypropyl) nitrosamine.

In order to evaluate the threshold dose of thyroid tumor-promoting effects of KA, male F344 rats were initiated with N-bis(2-hydroxypropyl) nitrosamine (DHPN; 2000 mg/kg body wt., single s.c. injection) and, starting 1 week later, received pulverized basal diet containing 0%, 0.002%, 0.008%, 0.03%, 0.125%, 0.5% or 2%KA for 20 weeks. Five rats each in the 0%, 0.125%, 0.5% and 2%KA groups were sacrificed at week 12, and 10 rats each in all groups at week 20. As an additional experiment, three groups without DHPN initiation received basal diet, a diet containing 0.5% or 2%KA for 20 weeks. The serum T4 levels were significantly decreased in the DHPN-initiated groups given 0.125%KA or more at week 12. No significant decreases in serum T3 levels were observed in the groups treated with DHPN + KA and a significant increase was evident in the 2%KA-alone group at week 20. Some rats in the DHPN + 2%KA group at weeks 12 and 20 and the 2%KA-alone group at week 20 showed pronounced elevation of serum TSH. Thyroid weights were significantly increased in the DHPN-initiated groups receiving 0.5% and 2%KA at weeks 12 and 20 and in the 2%KA-alone group at week 20. Histopathologically, the incidences of focal thyroid follicular cell hyperplasias in the DHPN-initiated groups treated with 0.125%, 0.5% and 2%KA at week 20 were 5/10, 10/10 and 8/8 rats, respectively. At week 20, adenomas were observed in 7/10 rats in the DHPN + 0.5%KA group and 8/8 rats in the DHPN + 2%KA group, and carcinomas were observed in 6/8 rats in the DHPN + 2%KA group. In the groups without DHPN initiation, only focal follicular cell hyperplasia was observed in 1/9 rats in the 2%KA-alone group. These results suggest that the no-observed-adverse effect for the thyroid tumor-promoting effect of KA is 0.03% (15.5 mg/kg/day) under the present experimental conditions, and that KA possesses weak tumorigenic activity in rats due to continuous serum TSH stimulation by a non-genotoxic mechanism.

[1]  K. Mitsumori,et al.  Time course observation of thyroid proliferative lesions and serum levels of related hormones in rats treated with kojic acid after DHPN initiation. , 1999, The Journal of toxicological sciences.

[2]  K. Mitsumori,et al.  Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in F344 rats. , 1999, Carcinogenesis.

[3]  S. Chimenti,et al.  The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  K. Mitsumori,et al.  Inhibition of thyroid iodine uptake and organification in rats treated with kojic acid. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  K. Mitsumori,et al.  Promoting effects of kojic acid due to serum TSH elevation resulting from reduced serum thyroid hormone levels on development of thyroid proliferative lesions in rats initiated with N-bis(2-hydroxypropyl)nitrosamine. , 1999, Carcinogenesis.

[6]  H. Watanabe,et al.  Induction of thyroid tumours in (C57BL/6N x C3H/N)F1 mice by oral administration of kojic acid. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  G. Boorman,et al.  Follicular Cell Hyperplasia, Adenoma, and Carcinoma, Thyroid, Rat , 1996 .

[8]  V. Kahn.  Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase. , 1995, Pigment cell research.

[9]  F. García-Carmona,et al.  Kojic Acid, a Cosmetic Skin Whitening Agent, is a Slow‐binding Inhibitor of Catecholase Activity of Tyrosinase , 1994, The Journal of pharmacy and pharmacology.

[10]  K. Mitsumori,et al.  Thyroid proliferative lesions induced by anti-thyroid drugs in rats are not always accompanied by sustained increases in serum TSH. , 1994, The Journal of toxicological sciences.

[11]  K. Mitsumori,et al.  Time course observation of thyroid proliferative lesions and serum TSH levels in rats treated with thiourea after DHPN initiation. , 1994, Cancer letters.

[12]  T. Nishimune,et al.  Genotoxicity of Environmental Mutagens in a Drosophila DNA-repair Test , 1993 .

[13]  Y. Monden,et al.  Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma , 1993, Cancer.

[14]  I. Dos Santos Silva,et al.  Sex differences in the risks of hormone-dependent cancers. , 1993, American journal of epidemiology.

[15]  N. Konishi,et al.  Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. , 1993, Oncology.

[16]  R M McClain,et al.  Thyroid gland neoplasia: non-genotoxic mechanisms. , 1992, Toxicology letters.

[17]  C. Wei,et al.  Mutagenicity studies of kojic acid. , 1991, Toxicology letters.

[18]  Murat O. Balaban,et al.  Inhibitory effect of kojic acid on some plant and crustacean polyphenol oxidases , 1991 .

[19]  Joseph K. Haseman,et al.  Use of Historical Control Data in Carcinogenicity Studies in Rodents , 1984, Toxicologic pathology.

[20]  D. Wynford‐Thomas,et al.  Desensitisation of rat thyroid to the growth-stimulating action of TSH during prolonged goitrogen administration. Persistence of refractoriness following withdrawal of stimulation. , 1982, Acta Endocrinologica.

[21]  T. Shibuya,et al.  Mutagenicity and dominant lethal test of kojic acid--Ames test, forward mutation test in cultured Chinese hamster cells and dominant lethal test in mice. , 1982, The Journal of toxicological sciences.

[22]  D. Wynford‐Thomas,et al.  Dissociation of growth and function in the rat thyroid during prolonged goitrogen administration. , 1982, Acta endocrinologica.

[23]  B. Pool.  Genotoxic activity of an alkaloidal extract of Senecio nemorensis, ssp. fuchsii in Salmonella typhimurium and Escherichia coli-systems. , 1982, Toxicology.

[24]  F. Kato,et al.  Kojic Acid, a Tyrosinase Inhibitor from Aspergillus albus , 1979 .

[25]  J M Ward,et al.  Neoplastic and nonneoplastic lesions in aging F344 rats. , 1979, Toxicology and applied pharmacology.

[26]  G. Roberts,et al.  Observations on the thyroid gland in rats following the administration of sulfamethoxazole and trimethoprim. , 1973, Toxicology and applied pharmacology.

[27]  V. Sidel,et al.  Adverse reactions to sulfisoxazole, sulfamethoxazole, and nitrofurantoin. Manifestations and specific reaction rates during 2,118 courses of therapy. , 1971, Archives of internal medicine.

[28]  F. W. Parrish,et al.  Production of aflatoxins and kojic acid by species of Aspergillus and Penicillium. , 1966, Applied microbiology.

[29]  W. Eisenman,et al.  Kojic acid as an inhibitor of tubercle bacilli. , 1950, American review of tuberculosis.